Compare BRBS & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRBS | EBS |
|---|---|---|
| Founded | 1893 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.4M | 434.4M |
| IPO Year | 2015 | 2006 |
| Metric | BRBS | EBS |
|---|---|---|
| Price | $3.97 | $8.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 234.7K | ★ 1.0M |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 6.31% | N/A |
| EPS Growth | 88.64 | ★ 125.83 |
| EPS | 0.07 | ★ 0.93 |
| Revenue | $111,284,000.00 | ★ $742,900,000.00 |
| Revenue This Year | N/A | $29.50 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $56.57 | ★ $8.80 |
| Revenue Growth | ★ 123.99 | N/A |
| 52 Week Low | $2.92 | $4.02 |
| 52 Week High | $4.79 | $14.06 |
| Indicator | BRBS | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 34.30 | 28.26 |
| Support Level | $3.37 | $7.66 |
| Resistance Level | $4.10 | $9.68 |
| Average True Range (ATR) | 0.11 | 0.54 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 16.87 | 7.40 |
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.